基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 生化试剂 激动剂抑制剂 6-异丙基-7-氧代-5-苯基-4,7-二氢吡唑并[1,5-A]嘧啶-3-腈 CPI-455
  • aladdin 阿拉丁 C419976 CPI-455 1628208-23-0 98%

aladdin 阿拉丁 C419976 CPI-455 1628208-23-0 98%

CPI-455
1628208-23-0
849.90 1ml 起订
上海 更新日期:2026-06-10

上海阿拉丁生化科技股份有限公司

VIP3年
联系人:阿拉丁客服
电话:6206333拨打
手机:13167063860 拨打
邮箱:anhua.mao@aladdin-e.com

产品详情:

中文名称:
CPI-455
英文名称:
CPI-455
CAS号:
1628208-23-0
品牌:
阿拉丁
产地:
上海
保存条件:
-80℃储存
纯度规格:
10mM in DMSO
产品类别:
小分子和化合物库 配体家族
分子式:
C16H14N4O
分子量:
278.31
运输条件:
特低温运输
产品规格:
1ml
货号:
C580333
是否进口:

中文名:CPI-455

英文名:CPI-455

纯度:10mM in DMSO

货号:C580333

Cas号:1628208-23-0

存储温度:-80℃储存

运输条件:特低温运输

产品介绍:

CPI-455 is a specific, pan- KDM5 inhibitor with an IC 50 of 10 nM for KDM5A. CPI-455 mediates KDM5 inhibition, elevates global levels of H3K4me3, and decreases the number of drug-tolerant persister cancer cells in multiple cancer cell line models treated with standard chemotherapy or targeted agents

In Vitro

CPI-455 mediates KDM5 inhibition, elevates global levels of H3K4 trimethylation (H3K4me3) and decreases the number of DTPs in multiple cancer cell line models treated with standard chemotherapy or targeted agents. ?\nCPI-455, with high measured affinity for the target KDM5 proteins. Within 24 hours, increases in H3K4me3, are observed after exposure to either of the two active compounds, CPI-455 and CPI-766, in a dosedependent manner. IC 50 calculation for KDM5 Inhibitor CPI0455 in 3 luminal breast cancer cell lines MCF-7, T-47 and EFM-19 are 35.4, 26.19 and 16.13 μM, respectively. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Dual blockade of B7-H4 and KDM5B (CPI-455, 50/70 mg/kg, ip, daily) in mice elicits protective immunity. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Six-week-old male C57BL/6 mice (One- to 2-mm fragments of P. gingivalis –positive PDXs were implanted subcutaneously into the flank region of humanized mice.) Dosage: 50 mg/kg or 70 mg/kg (combined with anti–B7-H4). Administration: IP, daily, 14-28 days. Result: Histopathology analysis revealed no inflammation in either group at 2 weeks in response to the primary infection. However, at 8 weeks after inoculation, mice receiving monotherapy exhibited mild inflammation, whereas the combined treatment presented with heavy to severe inflammation, which persisted at 12 and 16 weeks after challenge. Treatment with CPI-455 to selectively target H3K4-specific JmjC demethylases increased CXCL11, CXCL9, and CXCL10 following infection, with maximum levels observed 48 hours after infection.

Form:Solid

IC50& Target:KDM5


查看阿拉丁官网此产品相关对应页面:https://www.aladdin-e.com/zh_cn/C580333.html


CPI-455;CPI-455;1628208-23-0

公司简介

上海阿拉丁生化科技股份有限公司是A股上市公司((股票代码:688179),专注于科研试剂的研发、生产和销售,已陆续建立多个工厂和研发中心。作为领军企业,阿拉丁始终坚持质量第一,连续13年被评为“最受欢迎试剂品牌”。 阿拉丁目前常备库存试剂产品品种超过7万种,SKU总数超过46万,产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域,是国内少数化学试剂到生物试剂全面发展的国产试剂品牌,产品同步发布在我们国内外电商平台。

成立日期 (18年)
注册资本 14130.676万人民币
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂,试剂
主营行业 生物化工,化学试剂

CPI-455相关厂家报价

  • CPI-203
  • CPI-203
  • 河南伊诺凯新材料有限公司 VIP
  • 2026-06-10
  • 询价
  • CPI-818
  • CPI-818
  • 西安奕诺生物科技有限公司 VIP
  • 2026-04-30
  • ¥600
内容声明
拨打电话 立即询价